Ra Capital Nexus Fund Iii, L.p. - Net Worth and Insider Trading

Ra Capital Nexus Fund Iii, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ra Capital Nexus Fund Iii, L.p. owns 1 companies in total, including Mineralys Therapeutics Inc (MLYS) .

Click here to see the complete history of Ra Capital Nexus Fund Iii, L.p.’s form 4 insider trades.

Insider Ownership Summary of Ra Capital Nexus Fund Iii, L.p.

Ticker Comapny Transaction Date Type of Owner
MLYS Mineralys Therapeutics Inc 2023-02-09 director & 10 percent owner

Ra Capital Nexus Fund Iii, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ra Capital Nexus Fund Iii, L.p. Ownership Network

Ownership Network List of Ra Capital Nexus Fund Iii, L.p.

No Data

Ownership Network Relation of Ra Capital Nexus Fund Iii, L.p.

Insider Network Chart

Ra Capital Nexus Fund Iii, L.p. Owned Company Details

What does Mineralys Therapeutics Inc do?

Who are the key executives at Mineralys Therapeutics Inc?

Ra Capital Nexus Fund Iii, L.p. is the director & 10 percent owner of Mineralys Therapeutics Inc. Other key executives at Mineralys Therapeutics Inc include Chief Medical Officer David Malcom Rodman , director & Chief Executive Officer Jon Congleton , and CFO & Chief Bus. Off. and Secy. Adam Scott Levy .

Mineralys Therapeutics Inc (MLYS) Insider Trades Summary

Over the past 18 months, Ra Capital Nexus Fund Iii, L.p. made no insider transaction in Mineralys Therapeutics Inc (MLYS). Other recent insider transactions involving Mineralys Therapeutics Inc (MLYS) include a net sale of 142,377 shares made by Jon Congleton , a net sale of 262,849 shares made by David Malcom Rodman , and a net sale of 118,329 shares made by Adam Scott Levy .

In summary, during the past 3 months, insiders sold 56,536 shares of Mineralys Therapeutics Inc (MLYS) in total and bought 0 shares, with a net sale of 56,536 shares. During the past 18 months, 1,084,305 shares of Mineralys Therapeutics Inc (MLYS) were sold and 566,305 shares were bought by its insiders, resulting in a net sale of 518,000 shares.

Mineralys Therapeutics Inc (MLYS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Mineralys Therapeutics Inc Insider Transactions

No Available Data

Ra Capital Nexus Fund Iii, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Ra Capital Nexus Fund Iii, L.p.. You might contact Ra Capital Nexus Fund Iii, L.p. via mailing address: 200 Berkeley Street, 18th Floor, Boston Ma 02116.